Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Emerald Health Sciences Inc. | 10% Owner | 13 | $0 | $0 | 2019-02-01 |
| DHILLON PUNIT | Director | 1 | $0 | $0 | 2018-10-10 |
| HEPPELL JAMES L | Director | 1 | $0 | $0 | 2018-10-10 |
| DHILLON AVTAR S | Director | 1 | $0 | $0 | 2018-10-10 |
| Cesario Douglas A | CFO and Secretary | 2 | $0 | $0 | 2018-07-23 |
| Murphy Brian Stuart | Chief Medical Officer | 4 | $0 | $0 | 2018-01-18 |
| Berecz Elizabeth | Chief Financial Officer | 4 | $0 | $0 | 2018-01-18 |
| LYKOS COSMAS N | Chairman | 3 | $0 | $0 | 2018-01-18 |
| Lapham Reg Alexander | 10% Owner | 1 | $0 | $0 | 2017-03-13 |
| McLaughlin Gerald W. | Director | 6 | $25.0K | $0 | 2015-10-20 |
| GEORGE THOMAS | Director | 2 | $0 | $0 | 2015-10-20 |
| INGRAM DOUGLAS S | Vice Chairman | 4 | $0 | $0 | 2015-10-20 |
| Ladin Brian D | 10% Owner | 3 | $0 | $241.9K | 2015-04-10 |
| Hollister John B | Chief Executive Officer | 2 | $0 | $0 | 2014-12-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Emerald Health Sciences Inc. | 10% Owner | J Other deriv | 2019-02-01 | 2019-02-01 | 0 | — | $0 | 0 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | J Other deriv | 2019-02-01 | 2019-02-01 | 2,500,000 | — | $0 | 2,500,000 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | J Other | 2018-12-27 | 2018-12-28 | 37,667 | — | $0 | 73,153,917 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | J Other deriv | 2018-11-01 | 2018-11-01 | 2,500,000 | — | $0 | 2,500,000 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | J Other deriv | 2018-11-01 | 2018-11-01 | 0 | — | $0 | 0 | SEC↗ |
| DHILLON PUNIT | Director | A Award deriv | 2018-10-10 | 2018-10-12 | 200,000 | — | $0 | 200,000 | SEC↗ |
| HEPPELL JAMES L | Director | A Award deriv | 2018-10-10 | 2018-10-12 | 200,000 | — | $0 | 200,000 | SEC↗ |
| DHILLON AVTAR S | Director | A Award deriv | 2018-10-10 | 2018-10-12 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Cesario Douglas A | CFO and Secretary | A Award deriv | 2018-07-23 | 2018-07-23 | 1,195,073 | — | $0 | 1,195,073 | SEC↗ |
| Cesario Douglas A | CFO and Secretary | A Award | 2018-07-23 | 2018-07-23 | 643,501 | — | $0 | 643,501 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | C Conversion deriv | 2018-03-29 | 2018-04-03 | 2,000 | — | $0 | 0 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | C Conversion deriv | 2018-03-29 | 2018-04-03 | 1,234 | — | $0 | 0 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | C Conversion | 2018-03-29 | 2018-04-03 | 12,335,000 | $0.10 | $1.23M | 53,116,250 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | C Conversion | 2018-03-29 | 2018-04-03 | 20,000,000 | $0.10 | $2.00M | 73,116,250 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | P Buy deriv | 2018-02-16 | 2018-02-21 | 20,400,000 | — | $0 | 20,400,000 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | P Buy | 2018-02-16 | 2018-02-21 | 15,000,000 | — | $0 | 39,000,000 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | X Exercise deriv | 2018-01-24 | 2018-03-02 | 1,781,250 | — | $0 | 0 | SEC↗ |
| Emerald Health Sciences Inc. | 10% Owner | X Exercise | 2018-01-24 | 2018-03-02 | 1,781,250 | — | $0 | 40,781,250 | SEC↗ |
| Berecz Elizabeth | Chief Financial Officer | A Award | 2018-01-18 | 2018-01-22 | 700,000 | — | $0 | 1,050,000 | SEC↗ |
| LYKOS COSMAS N | Chairman | A Award | 2018-01-18 | 2018-01-22 | 900,000 | — | $0 | 4,599,400 | SEC↗ |
| Murphy Brian Stuart | CEO, Chief Medical Officer | A Award | 2018-01-18 | 2018-01-22 | 900,000 | — | $0 | 1,275,000 | SEC↗ |
| Lapham Reg Alexander | 10% Owner | X Exercise | 2017-03-13 | 2017-03-28 | 119,700 | $1.00 | $119.7K | 3,787,500 | SEC↗ |
| Murphy Brian Stuart | CEO, Chief Medical Officer | A Award | 2015-10-20 | 2015-10-22 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Berecz Elizabeth | Chief Financial Officer | A Award | 2015-10-20 | 2015-10-22 | 350,000 | — | $0 | 350,000 | SEC↗ |
| LYKOS COSMAS N | Chairman | A Award | 2015-10-20 | 2015-10-22 | 325,000 | — | $0 | 3,699,400 | SEC↗ |
| GEORGE THOMAS | Director | A Award | 2015-10-20 | 2015-10-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| McLaughlin Gerald W. | Director | A Award | 2015-10-20 | 2015-10-22 | 30,000 | — | $0 | 61,250 | SEC↗ |
| INGRAM DOUGLAS S | Vice Chairman | A Award | 2015-10-20 | 2015-10-22 | 60,000 | — | $0 | 372,500 | SEC↗ |
| McLaughlin Gerald W. | Director | C Conversion deriv | 2015-08-20 | 2015-08-24 | 10,000 | — | $0 | 0 | SEC↗ |
| INGRAM DOUGLAS S | Vice Chairman | C Conversion deriv | 2015-08-20 | 2015-08-24 | 100,000 | — | $0 | 0 | SEC↗ |
| McLaughlin Gerald W. | Director | C Conversion | 2015-08-20 | 2015-08-24 | 31,250 | — | $0 | 31,250 | SEC↗ |
| INGRAM DOUGLAS S | Vice Chairman | C Conversion | 2015-08-20 | 2015-08-24 | 312,500 | — | $0 | 312,500 | SEC↗ |
| INGRAM DOUGLAS S | Vice Chairman | A Award deriv | 2015-06-01 | 2015-06-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| McLaughlin Gerald W. | Director | P Buy deriv | 2015-05-29 | 2015-06-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| McLaughlin Gerald W. | Director | P Buy deriv | 2015-05-29 | 2015-06-02 | 10,000 | $2.50 | $25.0K | 10,000 | SEC↗ |
| Ladin Brian D | 10% Owner | S Sale | 2015-04-10 | 2015-04-10 | 11,830 | $4.93 | $58.3K | 249,098 | SEC↗ |
| Ladin Brian D | 10% Owner | S Sale | 2015-04-08 | 2015-04-10 | 15,800 | $4.79 | $75.7K | 260,928 | SEC↗ |
| Ladin Brian D | 10% Owner | S Sale | 2015-04-08 | 2015-04-10 | 23,000 | $4.69 | $107.9K | 276,728 | SEC↗ |
| GEORGE THOMAS | Director | A Award deriv | 2015-01-09 | 2015-01-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Hollister John B | Chief Executive Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Hollister John B | Chief Executive Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 480,000 | — | $0 | 480,000 | SEC↗ |
| Murphy Brian Stuart | Chief Medical Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 480,000 | — | $0 | 480,000 | SEC↗ |
| Murphy Brian Stuart | Chief Medical Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Berecz Elizabeth | Chief Financial Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Berecz Elizabeth | Chief Financial Officer | A Award deriv | 2014-12-04 | 2014-12-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| LYKOS COSMAS N | Chairman | A Award deriv | 2014-12-04 | 2014-12-08 | 125,000 | — | $0 | 125,000 | SEC↗ |
| McLaughlin Gerald W. | Director | A Award deriv | 2014-12-04 | 2014-12-08 | 20,000 | — | $0 | 20,000 | SEC↗ |